Transcriptomics

Dataset Information

0

Cancerous inhibitor of Protein Phosphatase 2A is a novel cell-autonomous regulator governing both T-and B-cell activation in vivo


ABSTRACT: The generation of optimal immune response requires combined activation of both T- and B-cells. Here, we demonstrate that the cancerous inhibitor of protein phosphatase 2A (CIP2A) is a novel factor that governs activation of both T- and B-cells in vivo. Upon ovalbumin challenge, CIP2A-deficient (CIP2AHOZ) mice show impaired immune response. Furthermore, CIP2AHOZ mice had impaired clearance of Listeria Monocytogenesis (L.m.) infection, combined with decreased numbers of CD8+ T-cells and IFN-γ secretion. In an ovalbumin model of allergic asthma, CIP2AHOZ B-cells were impaired in IgE and IgG secretion, despite of normal Th2 differentiation and unaffected numbers of inflammatory cells or cytokines in bronchoalveolar lavage. Importantly, the cell-autonomous effect of CIP2A deficiency for both T- and B-cell activation was confirmed by in vitro assays. During the T-cell activation CIP2A, was shown to promote expression of ETS-1, whereas in B-cells CIP2A loss resulted in inhibition of MYC-mediated gene expression. Together these results identify CIP2A as a novel cell-autonomous regulator governing both T- and B-cell activation in vivo. They also identify CIP2AHOZ as a novel murine model for investigation of impaired immune response and allergic asthma.

ORGANISM(S): Mus musculus

PROVIDER: GSE56401 | GEO | 2015/06/10

SECONDARY ACCESSION(S): PRJNA243188

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2015-06-10 | E-GEOD-56401 | biostudies-arrayexpress
2015-12-01 | GSE63391 | GEO
2010-06-10 | E-GEOD-6496 | biostudies-arrayexpress
2021-10-11 | GSE179874 | GEO
2007-07-01 | GSE6571 | GEO
2007-07-01 | GSE6496 | GEO
2024-11-06 | GSE281090 | GEO
2022-06-15 | GSE205761 | GEO
2016-06-01 | GSE75011 | GEO
2010-06-10 | E-GEOD-6571 | biostudies-arrayexpress